AML
Showing NaN - NaN of 7
MDS, AML Trial in France (venetoclax + azacitidine +/- donor lymphocyte infusion)
Not yet recruiting
- MDS
- AML
- venetoclax + azacitidine +/- donor lymphocyte infusion
-
Amiens, France
- +13 more
Jul 21, 2022
AML Trial in Worldwide (Flotetuzumab dose escalation, Flotetuzumab dose expansion, Ruxolitinib)
Active, not recruiting
- AML
- Flotetuzumab dose escalation
- +2 more
-
Duarte, California
- +42 more
Mar 7, 2022
MDS, AML, ALL Trial in France (Clofarabine in combination with IV busulfan and ATG)
Completed
- MDS
- +3 more
- Clofarabine in combination with IV busulfan and ATG
-
Lyon, France
- +5 more
Jul 18, 2017